Business Description

Description
OncoMed Pharmaceuticals Inc is a clinical-stage biotechnology company. The aim of the company is to address cancer initiation, growth, metastases, and recurrence by developing alternative therapies to fight cancer. Its core therapy uses monoclonal antibodies targeting cancer stem cells. The company has strategic alliances with Celgene, Bayer Pharma, and GlaxoSmithKline.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -57.89
12-1 Month Momentum % -69.86

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -102.47

GF Value Rank

Name Current Vs Industry Vs History
FCF Yield % -122.68

Financials

OMED's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:OMED

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

OncoMed Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 44.421
EPS (TTM) ($) -0.21
Beta 0
Volatility % 65.57
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % -69.86
52-Week Range ($) 0.55 - 3.35
Shares Outstanding (Mil) 38.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

OncoMed Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

OncoMed Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

OncoMed Pharmaceuticals Inc Frequently Asked Questions

What is OncoMed Pharmaceuticals Inc(OMED)'s stock price today?
The current price of OMED is $0.89. The 52 week high of OMED is $3.35 and 52 week low is $0.55.
When is next earnings date of OncoMed Pharmaceuticals Inc(OMED)?
The next earnings date of OncoMed Pharmaceuticals Inc(OMED) is .
Does OncoMed Pharmaceuticals Inc(OMED) pay dividends? If so, how much?
OncoMed Pharmaceuticals Inc(OMED) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1